Efficacy of a multidisciplinary approach on postoperative morbidity and mortality of elderly patients with hip fracture.
J Clin Anesth. 2018 Oct 1;53:11-19. doi:10.1016/j.jclinane.2018.09.029. Reguant F, Arnau A, Lorente JV, Maestro L, Bosch J.
Nutritional deficiencies and bone metabolism after endobarrier in obese type 2 patients with diabetes.
Eur J Clin Nutr. 2018 Oct;72(10):1447-1450. doi:10.1038/s41430-017-0074-x. Vilarrasa N, Fabregat A, Toro S, Gordejuela AG, Casajoana A, Montserrat M, Garrido P, López-Urdiales R, Virgili N, Planas-Vilaseca A, Simó-Servat A, Pujol J.
In situ gel-forming system for dual BMP-2 and 17β-estradiol controlled release for bone regeneration in osteoporotic rats.
Drug Deliv Transl Res. 2018 Oct;8(5):1103-1113. doi:10.1007/s13346-018-0574-9. Segredo-Morales E, Reyes R, Arnau MR, Delgado A, Évora C. https://www.ncbi.nlm.nih.gov/pubmed/30105738
Teriparatide Treatment Increases Mineral Content and Volume in Cortical and Trabecular Bone of Iliac Crest: A Comparison of Infrared Imaging With X-Ray-Based Bone Assessment Techniques.
J Bone Miner Res. 2018 Aug 13. doi: 10.1002/jbmr.3565. DOI: 10.1002/jbmr.3565 -PMID: 30102789 Paschalis EP(1), Krege JH(2), Gamsjaeger S(1), Eriksen EF(3), Burr DB(4), Disch DP(2), Stepan JJ(5), Fahrleitner-Pammer A(6), Klaushofer K(1), Marin F(2), PavoI(2). https://www.ncbi.nlm.nih.gov/pubmed/30102789
Adding Lateral Spine Imaging for Vertebral Fractures to Densitometric Screening: Improving Ascertainment of Patients at High Risk of Incident Osteoporotic Fractures.
J Bone Miner Res. 2018 Nov 5. doi: 10.1002/jbmr.3595. [Epub ahead of print] Prince RL(1)(2), Lewis JR(1)(3)(4), Lim WH(1)(5), Wong G(3), Wilson KE(6), Khoo BC(1)(7), Zhu K(1)(2), Kiel DP(8), Schousboe JT(9). DOI: 10.1002/jbmr.3595 -PMID: 30395687
Longitudinal changes in bone parameters in young girls with anorexia nervosa.
Bone. 2018 Nov;116:22-27. doi: 10.1016/j.bone.2018.03.022. Epub 2018 Mar 27. Shepherd S(1), Kyriakou A(1), Shaikh MG(1), McDevitt H(1), Oakley C(2), Thrower M(2), Ahmed SF(1), Mason A(3). DOI: 10.1016/j.bone.2018.03.022 -PMID: 29601899
Abaloparatide is an Effective Treatment Option for Postmenopausal Osteoporosis: Review of the Number Needed to Treat Compared with Teriparatide.
Calcif Tissue Int. 2018 Nov;103(5):540-545. doi: 10.1007/s00223-018-0450-0. Epub 2018 Jun 27. Reginster JY(1), Hattersley G(2), Williams GC(3), Hu MY(3), Fitzpatrick LA(3), Lewiecki EM(4). DOI: 10.1007/s00223-018-0450-0 -PMCID: PMC6182596 PMID: 29951742 https://www.ncbi.nlm.nih.gov/pubmed/29951742
Associations between sedentary time, physical activity and bone health among older people using compositional data analysis.
PLoS One. 2018 Oct 22;13(10):e0206013. doi: 10.1371/journal.pone.0206013.eCollection 2018. Rodríguez-Gómez I, Mañas A, Losa-Reyna J, Rodríguez-Mañas L, Chastin SFM, Alegre LM, García-García FJ, Ara I.
Bone mineral density response rates are greater in patients treated with abaloparatide compared with those treated with placebo or teriparatide: Results from the ACTIVE phase 3 trial.
Bone. 2018 Oct 22;120:137-140. doi: 10.1016/j.bone.2018.10.015 Miller PD(1), Hattersley G(2), Lau E(3), Fitzpatrick LA(4), Harris AG(5), Williams GC(4), Hu MY(4), Riis BJ(6), Russo L(7), Christiansen C(6). DOI: 10.1016/j.bone.2018.10.015 -PMID: 30359763
Denosumab effects on bone density and turnover in postmenopausal women with low bone mass with or without previous treatment.
Bone. 2018 Oct 4;120:44-49. doi: 10.1016/j.bone.2018.10.001. Tsourdi E(1), Makras P(2), Rachner TD(1), Polyzos S(3), Rauner M(1), Mandanas S(4), Hofbauer LC(5), Anastasilakis AD(6). DOI: 10.1016/j.bone.2018.10.001 -PMID: 30292818
